Gland Pharma Ltd
GLAND (NSE)

3,560.75

59,958.68
Proj. ROE (%)
19.57
Proj. P/E (x)
44.98
Proj EV / EBITDA (x)
35.83
Proj. P/BV (x)
8.13
Proj. Revenue ( Cr.)
4,513.24

Stock View

BUY
Share on
The average score for Gland Pharma Ltd stands at 7 against 7, three months back.

Gland Pharma Limited is an India-based company that manufactures small volume parenterals (SVPs). The Company provides a range of injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions and ophthalmic solutions. It provides contract development and manufacturing services, such as evaluation of development needs, identifying application program interface (API) sources, analytical method development, formulation development and product / technology know-how; and manufacturing of registration batches, studies, dossier compilation for regulatory submission and commercial production. The Company’s therapeutic categories include Anti-Infectives, Anaesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology, Gastro-Intestinal, Pain Management, Orthopaedics, Haematinics, Hormones and Related Drugs, Fertility Supplements, and Gnrh Agonists and Antagonists.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
3,677.32
100 DMA ()
3,811.24
200 DMA ()
3,304.91
52 Weeks Range
2,071.00
4,350.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity